IGF2BP3-STAT3-METTL3 axis promotes malignant progression in hepatocellular carcinoma (HCC)

Yang Xu, Yu Cao, Jingbo Yang, Xinghui Yu, Long Yang, Yan Xie, Jie Zhao, Yamin Zhang · 2025

Read IGF2BP3-STAT3-METTL3 axis promotes malignant progression in hepatocellular carcinoma (HCC) by Yang Xu, Yu Cao, Jingbo Yang, Xinghui Yu, Long Yang, Yan Xie, Jie Zhao, Yamin Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12849466.txt.

Description

Yang Xu and seven co-authors map a self-reinforcing RNA circuit that drives liver cancer forward. Hepatocellular carcinoma is usually caught late and shrugs off standard care. The circuit starts with IGF2BP3, a reader of chemical marks on RNA, which runs abnormally high in these tumors and tracks with poor survival. It grips and stabilizes the IL4R message, switching on the JAK2-STAT3 pathway.

STAT3 then helps park the mark-writing enzyme METTL3 inside the nucleus, through the adapter WTAP. That placement feeds more marking of IGF2BP3's own message, closing the loop. Cell growth assays and animal models confirmed the circuit's tumor push.

Catalog record

CREATORYang Xu, Yu Cao, Jingbo Yang, Xinghui Yu, Long Yang, Yan Xie, Jie Zhao, Yamin Zhang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12849466

Browse the full library · About the Tower of Babel